The idea of twelve defining Long COVID symptoms comes from the RECOVER study, a large federally funded research effort that in 2023 published the first data-driven index for identifying the condition. That original index scored twelve symptoms, and an updated 2024 version refined the list slightly, landing on eleven: postexertional malaise, fatigue, brain fog, dizziness, palpitations, changes in smell or taste, thirst, chronic cough, chest pain, shortness of breath, and sleep apnea. The shift from twelve to eleven reflects an evolving understanding rather than a settled catalog, and the biology behind each symptom reveals far more than a simple checklist can convey.
Where the List Comes From
The RECOVER (Researching COVID to Enhance Recovery) program enrolled thousands of adults across the United States to figure out which symptoms best distinguish people with Long COVID from those who recovered fully. Using statistical modeling, researchers identified symptoms that clustered together most reliably in people reporting ongoing illness. Each symptom on the index receives a point value, and a combined score of 11 or higher flags a person as having highly symptomatic Long COVID.1PubMed Central. 2024 Update of the RECOVER-Adult Long COVID Research Index The scoring system was never meant to be a diagnostic tool for individual patients in a clinic. It is a research instrument, designed to standardize who counts as a Long COVID case in studies so that findings across different institutions can be compared. That distinction matters because people with genuine Long COVID can score below the threshold if their particular combination of symptoms does not match the index’s weighting.
The original 2023 version of the index included gastrointestinal symptoms and changes in sexual desire or capacity among its twelve entries. The 2024 update dropped some of those and added shortness of breath and sleep apnea, reflecting new data from a larger follow-up cohort. So when you see references to “the twelve symptoms of Long COVID,” that refers to a specific moment in an ongoing research process rather than a permanent biological truth.
Postexertional Malaise and Fatigue
Postexertional malaise, often abbreviated PEM, sits at the top of the index for good reason. It describes a worsening of symptoms after physical or mental effort that would previously have been manageable. Someone with PEM might feel reasonably functional on a given day, take a short walk or attend a meeting, and then spend the next two to seven days dealing with amplified fatigue, pain, and cognitive problems. In one observational study, most Long COVID participants experienced this crash cycle, and about 59% met the same scoring thresholds used to diagnose postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).2PubMed Central. Chronic Fatigue and Postexertional Malaise in People Living With Long COVID: An Observational Study A separate study found that 58% of Long COVID participants met a full ME/CFS case definition, underscoring how much these two conditions overlap.3PubMed Central. ME/CFS and Post-Exertional Malaise among Patients with Long COVID
Recent research has started to explain what happens inside the body during these crashes. Muscle biopsies taken from Long COVID patients before and after maximal exercise showed that mitochondrial function, the cell’s energy-producing machinery, declined more sharply in patients than in healthy controls. A key enzyme involved in energy production dropped significantly in the patients but not in the control group, suggesting that reduced energy output and decreased mitochondrial content both contribute to the crash.4Nature Communications. Muscle abnormalities worsen after post-exertional malaise in long COVID This finding has practical implications: exercise programs that work for general deconditioning can actually make Long COVID patients worse if they push past their energy envelope.
Fatigue in Long COVID is listed as a separate index symptom from PEM, and the distinction is real. The fatigue is persistent and often unresponsive to rest, unlike normal tiredness after a bad night’s sleep. The overlap between Long COVID fatigue and ME/CFS-type fatigue extends to shared biological abnormalities across the nervous system, immune system, and energy metabolism.5PubMed Central. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature
Brain Fog
Brain fog is the colloquial term that patients themselves coined, and it has stuck in the medical literature because no clinical term captures the experience as well. It encompasses trouble concentrating, difficulty retrieving words, slowed processing speed, and a general feeling that thinking requires more effort than it used to. Unlike the cognitive decline associated with aging or neurodegeneration, brain fog in Long COVID often fluctuates with activity levels and can worsen dramatically during a PEM crash.
One line of research points to autoimmunity as a contributor. In Long COVID patients with neurological symptoms, autoantibodies targeting receptors involved in blood vessel regulation and autonomic nervous system signaling were significantly more prevalent than in recovered patients or healthy controls. The severity of cognitive symptoms correlated with the level of specific autoantibodies.6PubMed. Severity of neurological Long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors This suggests the immune system may be misfiring against the body’s own nerve and blood vessel receptors, disrupting the brain’s blood supply and signaling.
Dizziness, Palpitations, and the Autonomic Nervous System
Three symptoms on the index, dizziness, palpitations, and to some degree thirst, converge on a single underlying problem: autonomic dysfunction. Your autonomic nervous system controls heart rate, blood pressure, digestion, and body temperature without you thinking about it. When it malfunctions, standing up can cause a racing heart (palpitations), lightheadedness (dizziness), or both.
The most studied form of this in Long COVID is postural orthostatic tachycardia syndrome, or POTS, where the heart rate spikes abnormally upon standing. In one study of highly symptomatic Long COVID patients, about 31% were diagnosed with POTS. Those patients were younger on average, overwhelmingly female, and had significantly lower physical activity and shorter walking distances than Long COVID patients without POTS.7PubMed. Prevalence and Clinical Impact of Postural Orthostatic Tachycardia Syndrome in Highly Symptomatic Long COVID A multicenter UK study found that more than half of Long COVID patients developed symptoms of orthostatic intolerance during a standardized lean test, though only about 15% met the strict diagnostic criteria for POTS or orthostatic hypotension. Half of those with abnormal test results had never previously reported typical dizziness or palpitation symptoms, meaning the problem can be present even when people do not recognize it.8PubMed. Prevalence of orthostatic intolerance in long covid clinic patients and healthy volunteers: A multicenter study
POTS is not unique to Long COVID. It can also follow Epstein-Barr virus infections and other triggers. But the rate appears to be higher after COVID. In one comparison, all Long COVID patients in the study met POTS criteria, compared to 43% of post-Epstein-Barr patients and 50% of those with gradual-onset ME/CFS.9PubMed Central. Orthostatic Intolerance in Long-Haul COVID after SARS-CoV-2: A Case-Control Comparison with Post-EBV and Insidious-Onset Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
Thirst, which might seem like an odd entry on a defining symptom list, likely reflects the same autonomic disruption. When the body struggles to regulate blood volume and blood pressure, increased thirst is a compensatory signal. It is one of the symptoms that distinguishes the Long COVID index from a generic list of post-viral complaints.
Small Fiber Neuropathy as a Hidden Driver
Many of the autonomic symptoms in Long COVID, along with pain, tingling, and internal tremor sensations, may trace to damage to small nerve fibers in the skin and organs. In a cohort study of Long COVID patients, 82% had abnormal skin biopsies showing reduced nerve fiber density, and every patient with autonomic complaints had biopsy-confirmed abnormalities.10PubMed. Small Fiber Neuropathy in Long COVID: A Cohort Study with Multimodal Assessment and Follow-Up A separate case-control study found that roughly half of patients experiencing painful Long COVID symptoms met diagnostic criteria for small fiber neuropathy.11PubMed. Small fibre neuropathy frequently underlies the painful long-COVID syndrome These small nerves control sweat glands, blood vessel diameter, and gut motility, so their damage can explain an unusually wide range of seemingly unrelated symptoms.
Chest Pain and Shortness of Breath
Chest pain and shortness of breath both point to cardiovascular and pulmonary dysfunction that can persist long after the initial infection clears. Research suggests that endothelial dysfunction, meaning damage to the cells lining blood vessels, plays a central role. In a clinical trial, Long COVID patients with chest pain and palpitations were treated with sulodexide, a drug that supports endothelial repair. About 84% of the treated group saw chest pain improve, compared to 44% with no treatment, and palpitations improved at similar rates. The degree of endothelial function recovery correlated with symptom relief.12PubMed Central. Sulodexide Significantly Improves Endothelial Dysfunction and Alleviates Chest Pain and Palpitations in Patients With Long-COVID-19: Insights From TUN-EndCOV Study
The vascular damage in Long COVID appears to involve persistent inflammation of blood vessel walls, overactive platelets, and the formation of abnormal microclots made of fibrin, a clotting protein, in an amyloid-like configuration that resists the body’s normal clot-dissolving processes.13PubMed Central. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications These microclots can clog capillaries and restrict oxygen delivery to tissues, which could explain why so many Long COVID symptoms, from breathlessness to brain fog to fatigue, seem like different expressions of the same underlying oxygen-starved state.14PubMed Central. Long COVID: pathophysiological factors and abnormalities of coagulation
Changes in Smell or Taste
Loss of smell was one of the earliest recognized COVID symptoms, and for some people it never fully returned. Biopsy studies of the olfactory lining inside the nose have revealed that even months after SARS-CoV-2 is undetectable in the tissue, immune cells, particularly T cells producing inflammatory signals, remain embedded there. This persistent immune infiltration appears to reduce the number of olfactory sensory neurons, which are the cells that actually detect odors.15Science Translational Medicine. Persistent post-COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium The virus is long gone, but the immune system keeps reacting as though something is still wrong, damaging the tissue it is trying to protect.
Taste changes often accompany smell loss because much of what we perceive as flavor depends on olfactory input. Some people also report distorted smell, called parosmia, where previously pleasant scents become repulsive. These sensory disruptions can persist for over a year and have a surprisingly large effect on quality of life, affecting appetite, nutrition, safety (not smelling smoke or gas), and emotional well-being.
Chronic Cough and Sleep Apnea
Chronic cough persisting beyond the acute infection can reflect ongoing airway inflammation, hyperreactive airways, or nerve sensitization in the throat and chest. It is a straightforward respiratory symptom that most people associate with post-viral illness generally, but its inclusion on the Long COVID index reflects that it persists at higher rates and for longer durations than typical post-cold coughs.
Sleep apnea is the more surprising entry. Its appearance on the 2024 updated index suggests that Long COVID may either trigger new sleep apnea or worsen previously subclinical cases. The mechanism is still being investigated, but autonomic dysfunction affecting airway muscle tone during sleep is one hypothesis. This is worth watching for because untreated sleep apnea compounds fatigue, brain fog, and cardiovascular strain, all symptoms that are already elevated in Long COVID.
The Gut Connection
Gastrointestinal symptoms were included in the original 2023 RECOVER index but did not appear in the refined 2024 list. That does not mean they disappeared from patients’ experience. Many people with Long COVID report nausea, diarrhea, bloating, and abdominal pain. Research has found that SARS-CoV-2 antigens can persist in the gastrointestinal tract, and the virus disrupts gut barrier integrity and alters the gut microbiome. These changes may contribute not only to digestive symptoms but also to chronic inflammation and even neuropsychiatric disturbances through the gut-brain axis.16PubMed Central. The Intestine in Acute and Long COVID: Pathophysiological Insights and Key Lessons The fact that GI symptoms fell off the refined scoring index reflects statistical weighting decisions, not a judgment that they are unimportant.
Who Is Most at Risk
Long COVID does not strike randomly. Female sex is consistently identified as a risk factor across studies. A meta-analysis of prospective cohort studies found women had about 1.5 times the odds of developing the condition compared to men, and prior hospitalization for the acute infection roughly doubled the risk.17PubMed Central. Long COVID Prevalence and Risk Factors: A Systematic Review and Meta-Analysis of Prospective Cohort Studies One prospective cohort study put the sex difference higher, finding that women had about 3.3 times the odds. That same study found older age was a risk factor, and, somewhat unexpectedly, active smoking was associated with higher risk than being a former smoker.18PubMed Central. Female gender is associated with long COVID syndrome: a prospective cohort study Pre-existing respiratory illness also increases vulnerability.19PubMed Central. Long COVID among healthcare workers: a narrative review of definitions, prevalence, symptoms, risk factors and impacts
Children develop Long COVID too, though their symptom patterns differ. A large study from the RECOVER program identified six distinct subphenotypes in pediatric patients, including respiratory, musculoskeletal, gastrointestinal, neurologic, cardiopulmonary, and multisystem clusters.20Oxford Academic / Open Forum Infectious Diseases. 1362. Pediatric long COVID subphenotypes: an EHR-based study from the RECOVER program The adult twelve-symptom framework does not map neatly onto children, so applying the RECOVER adult index to a teenager or younger child would miss the mark.
Recovery Trajectory
One of the most common questions people have after reading any symptom list is: does this get better? A two-year longitudinal study tracked participants from the first months after infection through 24 months. Symptoms and the proportion of people meeting Long COVID criteria peaked between six and twelve months post-infection, then gradually decreased. At six and twelve months, about 24% of surveyed participants had Long COVID. By 18 months that dropped to 15%, and by two years it was 6%. Over the full follow-up period, a third of all participants experienced Long COVID at some point.21PubMed Central. Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs at 6–12 Months Postinfection The trajectory is encouraging for many, but the 6% still affected at two years represents a substantial number of people given how many infections have occurred worldwide.
Toward Better Diagnosis
The RECOVER symptom index is a questionnaire, not a blood test. That is both its strength (easy to use) and its weakness (subjective, unable to capture people who underreport symptoms). Researchers are actively pursuing blood-based biomarkers. One study found that a combination of three proteins in the blood could identify Long COVID patients with neurological symptoms with about 90% accuracy, and adding more biomarkers pushed accuracy close to 100%.22Brain, Behavior, & Immunity – Health. Blood diagnostic biomarkers for neurologic manifestations of long COVID These biomarkers are still in the research phase and are not available in routine clinical care, but they point toward a future where Long COVID can be confirmed objectively rather than diagnosed by exclusion.
Treatments Under Investigation
No single treatment has been approved specifically for Long COVID, but the evidence base is growing. A 2026 narrative review cataloged the state of trials and found that six out of fourteen prioritized interventions had at least some randomized controlled trial evidence specific to Long COVID. Exercise programs had the most trial data, though their design must account for PEM to avoid making patients worse. Other interventions with at least preliminary RCT support included multicomponent rehabilitation packages, coenzyme Q10, antivirals, vagus nerve stimulation, and monoclonal antibodies. For most treatments, the evidence was rated low to very low certainty.23PubMed Central. Candidate treatments for long covid: a narrative review of expert and patient-driven priorities
Low-dose naltrexone, a repurposed drug originally used for addiction at higher doses, has attracted attention from patients and some clinicians. A systematic review and meta-analysis found statistically significant improvements in fatigue, brain fog, and headaches among Long COVID patients taking it, though the authors stressed that the existing studies are small and more rigorous trials are needed.24COVID. Does Low-Dose Oral Naltrexone Alleviate Symptoms of Long COVID? A Systematic Review and Meta-Analysis
The Economic Weight of It All
The individual and societal costs of Long COVID are staggering. Estimates put the average annual global economic burden at roughly a trillion dollars, with per-patient costs in the United States averaging about $9,000 annually. Lost earnings in the US alone come to an estimated $170 billion per year. Long COVID has been associated with increased unemployment, financial distress, and work impairment persisting for up to three years after infection.25PubMed Central. Economic burden of long COVID: macroeconomic, cost-of-illness and microeconomic impacts These numbers help explain why developing reliable diagnostics and effective treatments has become a public health priority that extends well beyond the clinic. When millions of working-age people are too fatigued, too cognitively impaired, or too dizzy to hold a job, the problem stops being purely medical and becomes economic infrastructure.